Concepedia

Marlene Dressman

MD

Statistics

Publications

6

Citations

533

H-Index

6

Active since

2003

Affiliations

Novartis (Switzerland)(Current)

Vanda Pharmaceuticals (United States)

Massanutten Regional Library

Marlene Dressman is an author at Novartis (Switzerland) specializing in medicine, leukemia cytogenetics, and clinical cytogenetics.

Publications per year

2003–2015

6

Publications

6

Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

Steven W. Lockley, Marlene Dressman, Louis Licamele et al. · The Lancet · 2015 · 293 citations

, , +10

Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.

Marlene Dressman, Alex S. Baras, Rachel Malinowski et al. · PubMed · 2003 · 104 citations

, , +13

Pharmacogenomic Analysis of Cytogenetic Response in Chronic Myeloid Leukemia Patients Treated with Imatinib

Lee Anne McLean, Insa Gathmann, Renaud Capdeville et al. · Clinical Cancer Research · 2004 · 80 citations

, , +15

Correlation of Major Cytogenetic Response with a Pharmacogenetic Marker in Chronic Myeloid Leukemia Patients Treated with Imatinib (STI571)

Marlene Dressman, Rachel Malinowski, Lee Anne McLean et al. · Clinical Cancer Research · 2004 · 23 citations · Full text

, , +16

Clinical assessment of drug–drug interactions of tasimelteon, a novel dual melatonin receptor agonist

Brian W. Ogilvie, Rosarelis Torres, Marlene Dressman et al. · The Journal of Clinical Pharmacology · 2015 · 21 citations · Full text

, , +11

1–5 of 6